The firm will share new overall survival data from the INAVO120 trial with regulators to support the breast cancer drug's approval.

Chronic Pain, that persists beyond the usual recovery period or occurs along with a chronic <a target=_blank href= ...

A.forall announced through its U.S. subsidiary, Milla Pharmaceuticals Inc., that it has received Abbreviated New Drug Application (ANDA) approval by the U.S. Food and Drug Administration (FDA) for a ...

Infant mortality in the U.S. has increased by 7% since the 2022 Dobbs v. Jackson U.S. Supreme Court decision overturned the ...

Shionogi’s oral antiviral for respiratory syncytial virus (RSV) has met its primary endpoint in a Phase II study that saw ...

India's pharmaceutical industry is set for growth, driven by strong market players, global reputation, and evolving trends.

From steering global giants like JP Morgan Chase, Costco, Pfizer, and Louis Vuitton, to reshaping industries with figures ...

If the drug is approved by the US Food and Drug Administration for the treatment of acute pain in January as expected, the ...

Tyra Biosciences, Inc. , a clinical-stage biotechnology company focused on developing next-generation precision medicines that target large opportunities in Fibroblast Growth Factor Receptor (FGFR) ...

Total proceeds of $530 million on $300 million original 2022 investment Proceeds strengthen balance sheet and provide added flexibility to pursue disciplined capital allocation strategy, including sig ...

As more United States drug price changes have come to light this month, it remains clear that companies are tamping down ...

Results from DENALI Part 1b show an Objective Response Rate (ORR) of ~35% in response-evaluable, heavily-pretreated patients with Cyclin E1+ ...